Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen G Mainz

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Scientific Reports|December 14, 2017
Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis PatientsHarold Tabori, Anke Jaudszus, Christin Arnold, et al.
Pediatric Pulmonology|February 13, 2026
Relating Improvement in Gastrointestinal (CFAbd-Score<sup>©</sup>) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF PatientsJochen G Mainz, Vivien Greiner, Pauline Sadrieh, et al.
The Patient|March 20, 2019
Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score)Anke Jaudszus, Elisa Zeman, Tatjana Jans, et al.
Pediatric Pulmonology|February 6, 2020
Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patientsRenan M Mauch, Julia Hentschel, Kasper Aanaes, et al.
Case Reports in Infectious Diseases|April 14, 2015
Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive ConceptsJochen G Mainz, Andrea Gerber, Michael Lorenz, et al.
Mediators of Inflammation|July 18, 2015
Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic TherapyUlrike Müller, Julia Hentschel, Wibke K Janhsen, et al.
Nutrients|April 11, 2020
Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other FormsBernard Cuenoud, Isabelle Rochat, Maria Laura Gosoniu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 6, 2014
Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trialJochen G Mainz, Claudia Schien, Isabella Schiller, et al.
European Journal of Pediatrics|January 26, 2012
Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?Julia Hentschel, Gabriele Riesener, Heike Nelle, et al.
Journal of Immunological Methods|December 28, 2013
Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseasesJulia Hentschel, Ulrike Müller, Franziska Doht, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Scientific Reports|December 14, 2017
Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis PatientsHarold Tabori, Anke Jaudszus, Christin Arnold, et al.
Pediatric Pulmonology|February 13, 2026
Relating Improvement in Gastrointestinal (CFAbd-Score<sup>©</sup>) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF PatientsJochen G Mainz, Vivien Greiner, Pauline Sadrieh, et al.
The Patient|March 20, 2019
Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score)Anke Jaudszus, Elisa Zeman, Tatjana Jans, et al.
Pediatric Pulmonology|February 6, 2020
Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patientsRenan M Mauch, Julia Hentschel, Kasper Aanaes, et al.
Case Reports in Infectious Diseases|April 14, 2015
Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive ConceptsJochen G Mainz, Andrea Gerber, Michael Lorenz, et al.
Mediators of Inflammation|July 18, 2015
Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic TherapyUlrike Müller, Julia Hentschel, Wibke K Janhsen, et al.
Nutrients|April 11, 2020
Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other FormsBernard Cuenoud, Isabelle Rochat, Maria Laura Gosoniu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 6, 2014
Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trialJochen G Mainz, Claudia Schien, Isabella Schiller, et al.
European Journal of Pediatrics|January 26, 2012
Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?Julia Hentschel, Gabriele Riesener, Heike Nelle, et al.
Journal of Immunological Methods|December 28, 2013
Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseasesJulia Hentschel, Ulrike Müller, Franziska Doht, et al.
Pageof 8